Outcome | GEL (n = 20) | CSL (n = 20) | P value** |
---|---|---|---|
KDIGO stage*, n (%) | Â | Â | 0.73 |
 Stage I | 4 (20) | 7 (35) | – |
 Stage II | 1 (5) | 1 (5) | – |
 Stage III | 0 | 0 | – |
28-day RRT-free days | 28 (28–28) | 28 (28–28) | N/A |
Chest drain output (mL) | 485 (344–687) | 335 (268–428) | 0.05 |
Received blood products, n (%) | |||
 Packed red blood cells | 5 (25) | 0 (0) | 0.05 |
 Cryoprecipitate | 1 (5) | 0 (0) | N/A |
 Platelet concentrate | 1 (5) | 0 (0) | N/A |
Received albumin, n (%) | 2 (10) | 2 (10) | N/A |
Return to theatre, n (%) | 3 (15) | 0 (0) | 0.23 |
Ventilation time (hours) | 17 (11–30) | 11 (10–15) | 0.06 |
Fluid balance (mL) | 1751 (872–3022) | 1261 (688–2214) | 0.27 |
28-day ICU-free-days | 26 (24–27) | 26 (24–27) | 0.60 |
60-day mortality, n (%) | 0 (0) | 0 (0) | N/A |